Mumbai-based global pharma major Lupin, signed a distribution agreement with Slovenia-based Medis for Lupin’s orphan drug NaMuscla® (mexiletine). Medis will commercialize NaMuscla® for the symptomatic treatment of myotonia in adults with non-dystrophic myotonic (NDM) disorders in Central and Eastern European countries, namely Croatia, Czech Republic, Hungary, Slovakia, and Slovenia in...
Medis, Axantia, Source Orphan Drugs from India’s Lupin
Mumbai-based global pharma major Lupin, signed a distribution agreement with Slovenia-based Medis for Lupin’s orphan drug NaMuscla® (mexiletine). Medis will commercialize NaMuscla® for the symptomatic treatment of myotonia in adults with non-dystrophic myotonic (NDM) disorders in Central and Eastern European countries, namely Croatia, Czech Republic, Hungary, Slovakia, and Slovenia in...
India's Border Security to Pilot e-Scan Radar for Surveillance
Slovenia-based Dat-Con Defense, in partnership with Mumbai, India-based Ador Group, announced the integration of the Blighter B400 series e-scan radar into their command and control (C2) system. Dat-Con’s C2 security system is part of India’s pilot program to protect its international borders. The British designed and manufactured B400 series radar...